The behavioral health care industry has long been a strong player in the mergers and acquisitions (M&A) market. Even before the pandemic, investors were highly interested in subsectors like autism treatment, outpatient mental health, and substance use disorder (SUD) care. In 2018, there were 97 behavioral health deals, followed by another 85 in 2019. The pace was fast, competitive, and full of momentum heading into 2020.
Then COVID-19 struck, halting activity across nearly every sector. Behavioral health M&A slowed dramatically as buyers and sellers alike paused to assess the landscape. The uncertainty around patient volumes, government relief programs, and the overall economy made deal-making nearly impossible in the first half of the year.
Now, however, experts are predicting a strong comeback for behavioral health M&A in Q4 2020, with many of the delayed deals finally resuming. In fact, some see this as one of the busiest fourth quarters the industry has seen in years.
A Market on Pause, Not Collapse
Mike Moran, principal at American HealthCare Capital, explained that most behavioral health deals in early 2020 were not canceled but rather delayed. “As of four to six weeks ago, our phones have been ringing more steadily, and our engagements [with] potential sellers have picked up,” Moran said. “Our Q4 is lined up to be solid and just as robust as any other year.”
According to Moran, travel restrictions, the complexities of Paycheck Protection Program (PPP) loans, and new due diligence requirements slowed transactions down. Many buyers and sellers chose to wait until the environment stabilized. Now that the worst of those challenges are behind them, momentum is returning.
The prediction? Q4 could see a flood of pent-up activity as investors re-enter the behavioral health marketplace with renewed focus.
The Numbers Behind the Trends
Industry data backs up this optimism. Mertz Taggart, an M&A advisory firm, reported 25 behavioral health transactions in Q1 of 2020. That number fell to just 18 in Q2, as the pandemic disrupted operations and deal-making processes.
Burk Lindsey, managing director in the health care investment banking group at Raymond James & Associates, explained that this wasn’t due to declining interest in behavioral health but rather the shock of COVID-19. “Companies immediately went into bunker mentality because every operator had to figure out, ‘Okay, what does COVID mean for our business?’”
By late May and June, the picture started to clear. Patient volumes stabilized, telehealth adoption skyrocketed, and providers found ways to adapt. As a result, the deal market began to re-open. While the full Q3 report isn’t yet available, experts say activity clearly picked up and is poised to accelerate even further in Q4.
Subsector Hot Spots
Not all areas of behavioral health are rebounding equally, however. Lindsey noted that certain subsectors are seeing stronger demand than others. Outpatient mental health and services easily delivered via telehealth are particularly attractive to investors, thanks to their adaptability during the pandemic.
On the other hand, residential SUD treatment and autism therapy providers may face more challenges in the near term. These models rely heavily on in-person services, which are harder to deliver in a socially distanced environment. While long-term demand for these services remains strong, their short-term operational hurdles may slow down valuations and deal flow.
Still, overall interest in behavioral health remains extremely high. Buyers recognize the long-term growth potential, driven by rising demand for services, growing public awareness of mental health, and supportive policy trends.
Valuations Hold Steady
Despite the uncertainty of 2020, valuations in behavioral health have not declined significantly. Moran reported that multiples remain “just as solid and robust as they were pre-COVID.” For businesses that have weathered the storm, maintained profitability, and adapted to new realities, there is little reason to expect a discount.
This is encouraging news for sellers who feared the pandemic might drive down their company’s worth. As long as the business has remained healthy, valuations are strong and competitive.
Why Q4 Looks So Strong
A major reason Q4 is shaping up to be robust is the backlog of delayed deals from earlier in the year. Buyers and sellers who pressed pause in the spring and summer are now moving forward. This pent-up activity creates a ripple effect across the market, driving momentum.
Additionally, investors are under pressure to deploy capital. Private equity firms, in particular, raised large funds before the pandemic and need to invest that money. Behavioral health continues to be one of the most attractive industries for that capital.
With fewer opportunities available in some other sectors of health care, buyers are concentrating their attention on behavioral health. “There’s robust and more concentrated interest now,” Lindsey noted. “In many ways, buyers are more focused now because there are fewer opportunities in the market.”
Advice for Potential Sellers
For owners considering a sale, the message from experts is clear: The time is right. If your business has not been severely impacted by COVID-19 — or if it has even benefitted from the increased demand for behavioral health services — you may be in a strong position to sell.
“My advice to a business owner considering a transaction … would be to come on in,” Lindsey said. “The water’s fine.”
Sellers can expect strong valuations, significant interest from buyers, and a market that is hungry for opportunities. Waiting too long could risk missing the current wave of momentum.
The Bigger Picture
The return of M&A activity in behavioral health is not just about individual deals. It’s also a signal of confidence in the industry’s long-term outlook. Behavioral health has proven resilient through the pandemic, adapting quickly to telehealth, maintaining demand, and demonstrating its essential role in health care.
For investors, this resilience makes behavioral health a safe and promising place to put capital. For providers, it means opportunities for growth, partnerships, and expanded reach through new ownership structures.
As the fourth quarter of 2020 gets underway, all signs point to a highly active M&A landscape in behavioral health. The industry’s strong fundamentals, combined with pent-up deal flow and steady valuations, create a rare window of opportunity.
Conclusion
After a challenging year defined by COVID-19 delays and disruptions, the behavioral health M&A market is bouncing back with force. Experts predict Q4 will be one of the busiest periods in recent memory, driven by delayed transactions, steady valuations, and investor appetite for resilient sectors.
For potential sellers, the message from advisors is straightforward: Conditions are favorable, interest is high, and valuations are holding strong. As Moran and Lindsey suggest, there may be no better time to test the waters.
In other words — for behavioral health providers considering a sale — come on in. The water’s fine.
